Loading
Total declarations
Companies
▲ Purchases (70 ops.)
▼ Sales (0 ops.)
Latest filing published 16 May 2014 for Clovis Oncology, Inc..
Insider track record
Disclosed buys
70
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
70
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Edward J. McKinley: trading record in brief
Edward J. McKinley discloses dealings in 2 companies, chiefly Pharmion Corp and Clovis Oncology, Inc. In total, 82 filings cover trades dated from 3 March 2006 to 14 May 2014.
No open-market sale appears; the market trades are 70 purchases worth €2.2M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 option exercises.
A typical purchase (the median) is worth €11k.
The newest entry dates from 16 May 2014: a transaction, in Clovis Oncology, Inc. The last purchase on record was published on 16 August 2012, which is 5,181 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Edward J. McKinley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations82 total
85,000 shares0Common StockSEC:0001209191-14-034690:0
12,413 shares@ US$11.02Common StockSEC:0001209191-14-034690:1
12,414 shares@ US$19.46Common StockSEC:0001209191-14-034690:2
24,827 shares0Common StockSEC:0001209191-14-034690:3
24,827 shares0Common StockSEC:0001209191-14-034690:4
25,862 shares@ US$0.29Common StockSEC:0001181431-12-067568:0
6,896 shares@ US$3.08Common StockSEC:0001181431-12-067568:1
5,201 shares@ US$15.40Common StockSEC:0001181431-12-046134:0
Canonical exit: 12 Nov 2012 (T+90)
1,000 shares@ US$15.50Common StockSEC:0001181431-12-046134:1
Canonical exit: 13 Nov 2012 (T+90)
3,500 shares@ US$15.66Common StockSEC:0001181431-12-046134:2
Canonical exit: 14 Nov 2012 (T+90)
25,000 shares@ US$20.00Common StockSEC:0001181431-12-023207:0
Canonical exit: 9 Jul 2012 (T+90)
35,671 sharesCommon StockSEC:0001209191-11-057335:1
77,211 sharesCommon StockSEC:0001209191-11-057335:2
32,320 sharesCommon StockSEC:0001209191-11-057335:3
35,671 sharesCommon StockSEC:0001209191-11-057335:0
79,857 shares@ US$13.00Common StockSEC:0001209191-11-057335:4
Canonical exit: 19 Feb 2012 (T+90)
110,000 sharesCommon StockSEC:0001209191-08-043754:0
36 shares@ US$17.47Common StockSEC:0001209191-06-035822:0
Canonical exit: 6 Sept 2006 (T+90)
200 shares@ US$17.49Common StockSEC:0001209191-06-035822:1
Canonical exit: 6 Sept 2006 (T+90)
5,800 shares@ US$17.50Common StockSEC:0001209191-06-035822:2
Canonical exit: 6 Sept 2006 (T+90)
80 shares@ US$17.53Common StockSEC:0001209191-06-035822:3
Canonical exit: 6 Sept 2006 (T+90)
564 shares@ US$17.54Common StockSEC:0001209191-06-035822:4
Canonical exit: 6 Sept 2006 (T+90)
500 shares@ US$17.55Common StockSEC:0001209191-06-035822:5
Canonical exit: 6 Sept 2006 (T+90)
835 shares@ US$17.60Common StockSEC:0001209191-06-035822:7
Canonical exit: 6 Sept 2006 (T+90)
7 shares@ US$17.61Common StockSEC:0001209191-06-035822:8
Canonical exit: 6 Sept 2006 (T+90)
25 of 82 declarations
